Azamian Bobak R. 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Mar 20, 2025
Insider Transaction Report
Form 4
Azamian Bobak R.
DirectorPresident/CEO and Board Chair
Transactions
- Sale
Common Stock
2025-03-18$46.29/sh−7,131$330,094→ 70,720 total - Sale
Common Stock
2025-03-19$47.40/sh−8,551$405,317→ 62,169 total - Sale
Common Stock
2025-03-20$50.11/sh−8,534$427,639→ 53,635 total
Holdings
- 830,106(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F2]The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.